首页> 外文期刊>The American Journal of the Medical Sciences >Plasma Ghrelin Concentrations Are Negatively Correlated With Urine Albumin-to-Creatinine Ratio in Newly Diagnosed Type 2 Diabetes
【24h】

Plasma Ghrelin Concentrations Are Negatively Correlated With Urine Albumin-to-Creatinine Ratio in Newly Diagnosed Type 2 Diabetes

机译:在新诊断的2型糖尿病中血浆血浆Ghrelin浓度与尿白蛋白/肌酐比值负相关

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Aging is associated with a decrease in appetite, energy intake and glucose tolerance. Experimental studies have suggested that ghrelin and obestatin play a role in glucose homeostasis and in the regulation of energy metabolism. However, few studies have been performed on the role of ghrelin and obestatin in middle-aged and old adults. Methods: In the present study, we investigated the plasma concentrations of ghrelin and obestatin in middle-aged (41-64 years) and old (65-76 years) subjects with newly diagnosed type 2 diabetes mellitus (NDD) and normal glucose tolerance (NGT). We also characterized the relationship among plasma ghrelin and obestatin levels and glucose/ lipid metabolism. The fasting plasma ghrelin and obestatin concentrations were analyzed using enzyme immunoassay method. Results: Plasma obestatin concentrations in diabetic subjects were significantly lower than those in NGT subjects. Plasma ghrelin were negatively associated with fasting glucose, hemoglobin A1c, urine albumin-to-creatinine ratio (UACR) and positively correlated with high-density lipoprotein cholesterol. In addition, plasma obestatin level was correlated negatively with systolic blood pressure, triglycerides and total cholesterol. Furthermore, multiple regression analysis indicated that UACR was a significantly independent predictor of fasting plasma ghrelin levels. Conclusions: Collectively, ghrelin and obestatin levels may be markers reflecting glucose and lipid conditions in NDD. The lower ghrelin levels may be a potential indicator for renal dysfunction in patients with type 2 diabetes mellitus.
机译:背景:衰老与食欲,能量摄入和葡萄糖耐量下降有关。实验研究表明,生长素释放肽和肥胖抑制素在葡萄糖稳态和能量代谢调节中起作用。但是,关于生长素释放肽和肥胖抑制素在中老年人中的作用的研究很少。方法:在本研究中,我们调查了新诊断为2型糖尿病(NDD)和糖耐量正常的中年(41-64岁)和老年人(65-76岁)的生长激素释放肽和肥胖抑制素的血浆浓度( NGT)。我们还表征了血浆生长激素释放肽和肥胖抑制素水平与葡萄糖/脂质代谢之间的关系。使用酶免疫分析法分析禁食血浆生长素释放肽和肥胖抑制素的浓度。结果:糖尿病患者血浆中的肥胖抑制素浓度明显低于NGT患者。血浆生长素释放肽与空腹血糖,血红蛋白A1c,尿白蛋白与肌酐之比(UACR)呈负相关,与高密度脂蛋白胆固醇呈正相关。另外,血浆肥胖抑制素水平与收缩压,甘油三酸酯和总胆固醇呈负相关。此外,多元回归分析表明,UACR是空腹血浆生长素释放肽水平的显着独立预测因子。结论:总的来说,生长激素释放肽和肥胖抑制素水平可能是反映NDD中葡萄糖和脂质状况的标志。较低的生长素释放肽水平可能是2型糖尿病患者肾功能不全的潜在指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号